Recent achievements in CAR-T cell immunotherapy for glioblastoma treatment

Glioblastoma remains the most common and aggressive primary brain tumor today. Because of the neuroanatomical location of glioblastoma, conventional chemotherapy and radiation therapy have limited efficacy in patients with these tumors. Over the past decade, antitumor immunotherapy has become widesp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: S. V. Timofeeva, A. O. Sitkovskaya, I. A. Novikova, M. A. Ezhova, E. P. Lysenko, O. I. Kit
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2021
Materias:
Acceso en línea:https://doaj.org/article/bc84923f84924863a08fac30e16a46d8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!